Background: Diagnosis and treatment of latent tuberculosis infection (LTBI) is the most effective strategy to control tuberculosis (TB) among patients with HIV infection. The tuberculin skin test (TST ...
The T-SPOT.TB test is now the only interferon-gamma release assay (IGRA) cleared for use in children ages two and upwards in the United States OXFORD, United Kingdom and MARLBOROUGH, Mass., Sept. 29, ...
PerkinElmerās (NYSE: PKI) Oxford Immunotec today announced the U.S. Food and Drug Administration (FDA) has approved the use of the T-Cell Select⢠reagent kit for the automation of its T-SPOT ®.TB test ...
WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY) today announced the launch of the Auto-Pure 2400 liquid handler from Allsheng for use with the T-SPOT.TB test. The Auto-Pure 2400 platform ...
OXFORD, United Kingdom and MARLBOROUGH, Mass., July 20, 2020 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), today announced that it has entered into a long-term ...
Dear Dr. Roach: I had a tuberculosis (TB) skin test for my new job in May, and it was negative. They did a blood test in July. I have a question about a positive T-SPOT blood test for TB. They did a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results